Skip to content
Quality·Published 2026-08-08

Stability and storage of lyophilised peptides

A peptide's degradation routes, why the lyophilised state protects the molecule, and what to control on the COA and in the cold chain so a batch is still the same when it reaches the lab bench.

By MX-1 Labs Editorial Team

On this page

Producto para uso experimental en laboratorio. No es medicamento ni producto de consumo humano.

Research use only. This content is for laboratory research; not for human or veterinary use, diagnosis, or treatment.

Why stability decides reproducibility

A peptide with ≥99% purity at synthesis does not guarantee that the material entering an experiment weeks later is the same. Between manufacture and use come transport, storage and reconstitution, and each step exposes the molecule to degradation routes. For reproducible research, stability is not a logistical detail: it determines whether two experiments with the same batch are comparable.

A peptide's degradation routes

The literature on protein and peptide stability distinguishes two broad categories. Chemical degradation alters covalent structure: deamidation of asparagine and glutamine residues, oxidation of methionine and tryptophan, and hydrolysis of peptide bonds are the most frequent; all depend on water, temperature and pH [1].

Physical degradation breaks no bonds but does break the functional conformation: aggregation is the dominant route, and its driving force is often the exposure of hydrophobic regions that promote assembly into nonnative aggregates [2]. In aqueous solution both categories accelerate; that is why peptides are stored and shipped in the solid state whenever possible.

Why the lyophilised state protects

Lyophilisation (freeze-drying) is the most common method for preparing stable solid peptides, precisely because removing water halts hydrolytic routes and slows most degradation reactions [3]. But the process itself generates freezing and drying stresses, so the formulation (cryoprotectants, buffers) and the residual water content of the final product are critical variables.

This is where the Karl Fischer water content on the COA comes in: it is not decorative. High residual moisture in a lyophilisate shortens shelf life, because water reactivates the deamidation and hydrolysis routes that drying set out to halt. A low, declared value signals a product formulated to last.

Reconstitution and cold chain

Once reconstituted, the peptide is back in aqueous solution and the degradation clock restarts. That is why lyophilised material is kept at freezing temperatures (typically -20 °C) while reconstituted peptide is stored refrigerated (2-8 °C) and used within the window the protocol sets. Reconstitution is done with sterile bacteriostatic water following laboratory protocols, and repeated freeze-thaw cycles should be avoided because they promote aggregation [2].

What to look for on the COA about stability

Three Certificate of Analysis fields speak directly to stability: water content by Karl Fischer (the lower, the better for a lyophilisate), purity by HPLC alongside the related-substances profile (degradation products show up as extra peaks), and the batch expiry with its storage conditions. A COA that declares these three, and a cold chain that respects them, is what lets you claim the vial opened at the bench is equivalent to the one that left synthesis.

References

  1. [[1]] Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. PubMed
  2. [[2]] Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res. 2003;20(9):1325-1336. PubMed
  3. [[3]] Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PubMed

Related reading